levofloxacin tablet, film coated
aurobindo pharma limited - levofloxacin (unii: 6gnt3y5lmf) (levofloxacin anhydrous - unii:rix4e89y14) - levofloxacin anhydrous 250 mg - levofloxacin tablets are indicated in adult patients for the treatment of nosocomial pneumonia due to methicillin-susceptible staphylococcus aureus, pseudomonas aeruginosa, serratia marcescens, escherichia coli, klebsiella pneumoniae, haemophilus influenzae, or streptococcus pneumoniae . adjunctive therapy should be used as clinically indicated. where pseudomonas aeruginosa is a documented or presumptive pathogen, combination therapy with an anti-pseudomonal β-lactam is recommended [see clinical studies (14.1)] . levofloxacin tablets are indicated in adult patients for the treatment of community-acquired pneumonia due to methicillin-susceptible staphylococcus aureus, streptococcus pneumoniae (including multi-drug-resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae, haemophilus parainfluenzae, klebsiella pneumoniae, moraxella catarrhalis, chlamydophila pneumoniae, legionella pneumophila, or mycoplasma pneumoniae [see dosage and administration (2.1) and clinical studies (14.2 )]. mdrsp i
lithium carbonate- lithium carbonate capsule
camber pharmaceuticals, inc. - lithium carbonate (unii: 2bmd2gna4v) (lithium cation - unii:8h8z5uer66) - lithium carbonate 150 mg - lithium is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar i disorder: • treatment of acute manic and mixed episodes in patients 7 years and older [see clinical studies ( 14)] • maintenance treatment in patients 7 years and older [see clinical studies ( 14)] lithium is contraindicated in patients with known hypersensitivity to any inactive ingredient in the lithium carbonate capsule or lithium citrate products [see adverse reactions ( 6)]. risk summary: lithium may cause harm when administered to a pregnant woman. early voluntary reports to international birth registries suggested an increase in cardiovascular malformations, especially for ebstein’s anomaly, with first trimester use of lithium. subsequent case-control and cohort studies indicate that the increased risk for cardiac malformations is likely to be small; however, the data are insufficient to establish
glucovance 500/2.5 metformin hydrochloride 500 mg and glibenclamide 2.5 mg tablet blister pack
alphapharm pty ltd - metformin hydrochloride, quantity: 500 mg; glibenclamide, quantity: 2.5 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; povidone; magnesium stearate; microcrystalline cellulose; titanium dioxide; lactose monohydrate; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000; iron oxide black - second line treatment of diabetes mellitus type ii in adult patients whose glycaemic control is inadequate after diet and exercise alone and where combined therapy with metformin and glibenclamide is appropriate.
50% dextrose injection usp [wellpharma] 500 mg/ml infusion
al ittihad drug store united arab emirates - 500 ml polypropylene bag - infusion - 500 mg/ml - nutrition , blood-fluids , electrolytes
mycokem tablets 500 mg/tablet
al manarah medicine store llc india - 150's [3 x 50's (10's blister x 5)] - tablet - 500 mg/tablet - malignant disease,immunosuppresion-immune response
eromycin ® 500mg 500mg / tablet
julphar drug store l.l.c united arab emirates - 500's (10's blister x 50) - tablet - 500mg / tablet - infections-antibacterial
cetil 500 500mg / tablet
pharmalink store india - 10's blister - tablet - 500mg / tablet - infections-antibacterial
levomac 500 500 mg/tab tablet
propharma medical supplies india - 10's blister - tablet - 500 mg/tab - infections-antibacterial
kefrine 500 500 mg/tablet
pharmalink store india - 10's blister - tablet - 500 mg/tablet - infections-antibacterial
ciprodar® 500mg 500mg / tablet
al mufid pharmaceutical store l l c jordan - 10's (10's blister x 1) - tablet - 500mg / tablet - infections-antibacterial